Although Massachusetts leads the nation with the lowest rates of uninsurance, residents who are male, single, young, and low-income are more likely than others to be persistently without health insurance for two consecutive years. This was one of the findings of a report co-authored by researchers from UMass Medical School and the Commonwealth Health Insurance Connector Authority and funded by the Blue Cross Blue Shield of Massachusetts Foundation. The findings suggest that a variety of approaches are needed to reduce the number of residents who remain without health insurance.
Joyce A. Murphy, MPA, executive vice chancellor of UMass Medical School’s Commonwealth Medicine division, has been elected clerk of the Schwartz Center for Compassionate Healthcare Board of Directors.
An IT expert at UMass Medical School’s Eunice Kennedy Shriver Center will present about simplifying web text for people with intellectual disabilities and understanding user experience at the HCI International 2016 conference July 17-22 at the Westin Harbour Castle Hotel in Toronto.
UMass Medical School is conducting a cost analysis for the New England Asthma Innovation Collaborative (NEAIC) project launched to improve asthma outcomes and reduce the health care costs of children in four New England states.
The Eunice Kennedy Shriver Center’s emergency preparedness team is featured in a video by the National Center for Disaster Medicine & Public Health on health professionals and communities with access and functional needs working together to prepare for disasters.
Opioids are very effective for acute pain resulting from an injury or surgery, but they should not be used to treat chronic pain, a UMass Medical School opioids expert tells Worcester Business Journal’s Health quarterly.
UMass Medical School health policy experts will review updated enrollment and spending data on Massachusetts’ Medicaid program, MassHealth, in a webinar at noon June 29 hosted by the Blue Cross Blue Shield of Massachusetts (BCBSMA) Foundation.
A UMass Medical School pharmacy expert says the delay in the results of a trial on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors is frustrating for prescribers waiting to give the drugs to patients with uncontrolled cholesterol levels, according to an article in Specialty Pharmacy Continuum.
UMass Medical School health policy experts will discuss Affordable Care Act (ACA) and Medicaid waivers and newly issued federal guidance at an event June 28 sponsored by the Connecticut Health Foundation in collaboration with the Universal Health Care Foundation of Connecticut.
UMass Medical School experts will present on a variety of topics, including practice transformation, perioperative surgical home care, new medications for hepatitis C and behavioral health integration, at the annual AcademyHealth Research Meeting June 25-28 in Boston.
A study initiated at UMass Medical School and led by Brandeis University highlights unmet needs and barriers to care for women with physical disabilities during pregnancy and childbirth, including clinicians’ knowledge and attitudes and accessibility to health care facilities and equipment. The researchers said clinicians need training to better care for pregnant women with physical disabilities.
The United States Office of National Drug Control Policy has invited a UMass Medical School Health and Criminal Justice Program leader to speak at an event about substance use disorder treatments for justice-involved populations at the Eisenhower Executive Office Building in Washington, D.C., June 17.
A UMass Medical School pharmacy expert believes providers will wait for the results of more cardiovascular outcomes trials before prescribing proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors to manage their patients’ cholesterol levels, according to an article in Pharmacy Practice News.
A UMass Medical School study of Massachusetts Medicaid members suggests certain patients with hepatitis C face barriers to receiving the newest medications to treat the virus. The research paper published in the June edition of the Journal of Managed Care & Specialty Pharmacy says more patients must have access to the life-saving regimens.
Children with intellectual and developmental disabilities may face more risk factors for obesity than typically developing youths, but few studies have focused on obesity in those with disabilities, a researcher in UMass Medical School’s Eunice Kennedy Shriver Center told MedPage Today.